USP7 and neoplasm: Although the influence of these compounds on various pathways in the development of cancer malignancies has been investigated thoroughly, their ability to modulate anti-tumor immune response was evaluated only for a small number of previously reported USP7 inhibitors (Figure 2; Table 1).